. 2024 Aug 2;12:1431423. doi: 10.3389/fcell.2024.1431423
Copyright © 2024 Guo, Jiang, Lian, Li, Zhang, Xie, Deng, Hou, Du and Hao.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
FIGURE 1.
Evaluation of the effect of GSK-3β on liver cancer based on the Pl3K/AKT pathway.